EGFR expression and HER2/neu overexpression/amplification in endometrial carcinosarcoma
- 31 January 2006
- journal article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 100 (1), 101-106
- https://doi.org/10.1016/j.ygyno.2005.07.124
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- COX-2, c-KIT and HER-2/neu expression in uterine carcinosarcomas: prognostic factors or potential markers for targeted therapies?Gynecologic Oncology, 2005
- ERBB-2 gene overexpression and amplification in uterine sarcomasGynecologic Oncology, 2004
- Carcinosarcomas (Malignant Mullerian Mixed Tumors) of the Uterus and Ovary: A Genetic Study With Special Reference to HistogenesisInternational Journal of Gynecological Pathology, 2003
- Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomasInternational Journal of Gynecologic Cancer, 2002
- Malignant biphasic uterine tumours: carcinosarcomas or metaplastic carcinomas?Journal of Clinical Pathology, 2002
- A comparison of epidermal growth factor receptor levels and other prognostic parameters in non-small cell lung cancerEuropean Journal of Cancer, 1996
- Prognostic value of immunohistochemically detected HER-2/neu oncoprotein in endometrial cancerCancer Letters, 1996
- Multivariate survival analysis of clinicopathologic features in surgical stage I endometrioid carcinoma including analysis of HER-2/neu expressionAmerican Journal of Obstetrics and Gynecology, 1995
- Epidermal growth factor-related peptides and their receptors in human malignanciesCritical Reviews in Oncology/Hematology, 1995
- Epidermal growth factor receptors on human breast cancersBritish Journal of Surgery, 1985